Published in Value Health on January 22, 2013
Hydroxychloroquine in Systemic Lupus Erythematosus | NCT03802188
Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide. Patient (2015) 1.34
Incorporating patient-preference evidence into regulatory decision making. Surg Endosc (2015) 1.25
Concepts of 'personalization' in personalized medicine: implications for economic evaluation. Pharmacoeconomics (2015) 1.16
Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment. Arthritis Res Ther (2014) 1.11
Public preferences for the return of research results in genetic research: a conjoint analysis. Genet Med (2014) 0.97
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment. Patient (2016) 0.96
Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment. CMAJ (2015) 0.93
Measuring preferences for analgesic treatment for cancer pain: how do African-Americans and Whites perform on choice-based conjoint (CBC) analysis experiments? BMC Med Inform Decis Mak (2013) 0.93
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer. Eur J Health Econ (2014) 0.89
Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment. Br J Cancer (2013) 0.88
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom. Support Care Cancer (2014) 0.88
Effects of financial incentives on motivating physical activity among older adults: results from a discrete choice experiment. BMC Public Health (2014) 0.87
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient (2013) 0.87
A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany. Ther Adv Neurol Disord (2016) 0.86
Patient preferences in advanced or recurrent ovarian cancer. Cancer (2014) 0.85
Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One (2014) 0.85
Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment. Eur J Health Econ (2016) 0.84
Developing attributes and attribute-levels for a discrete choice experiment on micro health insurance in rural Malawi. BMC Health Serv Res (2014) 0.83
The Australian public's preferences for emergency care alternatives and the influence of the presenting context: a discrete choice experiment. BMJ Open (2015) 0.82
Physician preferences for extra-glycemic effects of type 2 diabetes treatments. Diabetes Ther (2013) 0.82
Investigating preferences for support with life after stroke: a discrete choice experiment. BMC Health Serv Res (2014) 0.81
Patient and nurse preferences for nurse handover-using preferences to inform policy: a discrete choice experiment protocol. BMJ Open (2015) 0.81
Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE). BMC Health Serv Res (2013) 0.80
Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment. Patient Prefer Adherence (2015) 0.80
Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues. Health Econ Rev (2016) 0.79
Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review. Patient (2017) 0.79
Modeling the Mental Health Practice Change Preferences of Educators: A Discrete-Choice Conjoint Experiment. School Ment Health (2014) 0.79
Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening. Value Health (2014) 0.79
Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview. Health Econ Rev (2016) 0.79
The Role of Qualitative Research Methods in Discrete Choice Experiments. Med Decis Making (2017) 0.79
Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in The Netherlands? A discrete choice experiment. PLoS One (2014) 0.78
Parents' preferences and willingness-to-pay for human papilloma virus vaccines in Thailand. J Pharm Policy Pract (2015) 0.78
Applying discrete choice modelling in a priority setting: an investigation of public preferences for primary care models. Eur J Health Econ (2013) 0.78
Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment. Patient Prefer Adherence (2016) 0.78
Using qualitative research to facilitate the interpretation of quantitative results from a discrete choice experiment: insights from a survey in elderly ophthalmologic patients. Patient Prefer Adherence (2016) 0.78
Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes. BMJ Open Diabetes Res Care (2016) 0.78
Exploring how individuals complete the choice tasks in a discrete choice experiment: an interview study. BMC Med Res Methodol (2016) 0.78
Simulation study to determine the impact of different design features on design efficiency in discrete choice experiments. BMJ Open (2016) 0.77
Prioritising patients for bariatric surgery: building public preferences from a discrete choice experiment into public policy. BMJ Open (2015) 0.77
Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease. PLoS One (2016) 0.77
Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments. J Thyroid Res (2015) 0.77
Physician preferences for bone metastasis drug therapy in Canada. Curr Oncol (2015) 0.77
Mothers' preferences regarding new combination vaccines for their children in Japan, 2014. Hum Vaccin Immunother (2016) 0.77
Acceptance of vaccinations in pandemic outbreaks: a discrete choice experiment. PLoS One (2014) 0.76
Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain. Patient Prefer Adherence (2016) 0.75
Parents and adolescents preferences for asthma control: a best-worst scaling choice experiment using an orthogonal main effects design. BMC Pulm Med (2015) 0.75
Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments. Patient Prefer Adherence (2017) 0.75
Stated Choice design comparison in a developing country: recall and attribute nonattendance. Health Econ Rev (2014) 0.75
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. PLoS One (2015) 0.75
Understanding patient preferences and willingness to pay for hemophilia therapies. Patient Prefer Adherence (2015) 0.75
Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. Patient Prefer Adherence (2016) 0.75
Using blocked fractional factorial designs to construct discrete choice experiments for healthcare studies. Stat Med (2016) 0.75
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors. Patient (2016) 0.75
The value of quantitative patient preferences in regulatory benefit-risk assessment. J Mark Access Health Policy (2014) 0.75
Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. Med Decis Making (2015) 0.75
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment. BMJ Open (2016) 0.75
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom. Diabetes Ther (2017) 0.75
Developing attributes for discrete choice experiments in health: a systematic literature review and case study of alcohol misuse interventions. J Subst Use (2016) 0.75
Women's Preferences for Treatment of Perinatal Depression and Anxiety: A Discrete Choice Experiment. PLoS One (2016) 0.75
Protective Behaviour of Citizens to Transport Accidents Involving Hazardous Materials: A Discrete Choice Experiment Applied to Populated Areas nearby Waterways. PLoS One (2015) 0.75
Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine. Value Health (2017) 0.75
Physician and patient benefit-risk preferences from two randomized long-acting injectable antipsychotic trials. Patient Prefer Adherence (2016) 0.75
Patients' preferences for attributes related to health care services at hospitals in Amhara Region, northern Ethiopia: a discrete choice experiment. Patient Prefer Adherence (2015) 0.75
Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis. Pharmacoeconomics (2016) 0.75
Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach. Patient Prefer Adherence (2016) 0.75
A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients. Ther Clin Risk Manag (2016) 0.75
Modeling the hospital safety partnership preferences of patients and their families: a discrete choice conjoint experiment. Patient Prefer Adherence (2016) 0.75
How to reform western care payment systems according to physicians, policy makers, healthcare executives and researchers: a discrete choice experiment. BMC Health Serv Res (2015) 0.75
Lost in the crowd? Using eye-tracking to investigate the effect of complexity on attribute non-attendance in discrete choice experiments. BMC Med Inform Decis Mak (2016) 0.75
Novel application of a discrete choice experiment to identify preferences for a national healthcare-associated infection surveillance programme: a cross-sectional study. BMJ Open (2016) 0.75
Understanding Preferences for Treatment After Hypothetical First-Time Anterior Shoulder Dislocation: Surveying an Online Panel Utilizing a Novel Shared Decision-Making Tool. Orthop J Sports Med (2017) 0.75
Household Size and the Decision to Purchase Health Insurance in Cambodia: Results of a Discrete-Choice Experiment with Scale Adjustment. Appl Health Econ Health Policy (2016) 0.75
Patient and nurse preferences for implementation of bedside handover: Do they agree? Findings from a discrete choice experiment. Health Expect (2016) 0.75
Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey. Diabetes Ther (2017) 0.75
Older People's Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice Experiment. Drugs Aging (2017) 0.75
Valuing Individuals' Preferences and Health Choices of Physical Exercise. Pain Ther (2017) 0.75
Evaluating the consequences of rheumatoid arthritis. Eur J Health Econ (2016) 0.75
Patient and Public Preferences for Treatment Attributes in Parkinson's Disease. Patient (2017) 0.75
Selection of key health domains from PROMIS(®) for a generic preference-based scoring system. Qual Life Res (2017) 0.75
Adolescent values for immunisation programs in Australia: A discrete choice experiment. PLoS One (2017) 0.75
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Res Treat (2017) 0.75
Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments. BMJ Open (2017) 0.75
Measuring customer preferences in the German statutory health insurance. Eur J Health Econ (2016) 0.75
Junior doctors' medical specialty and practice location choice: simulating policies to overcome regional inequalities. Eur J Health Econ (2016) 0.75
Hemodialysis patients' preferences for the management of secondary hyperparathyroidism. BMC Nephrol (2017) 0.75
Hemodialysis patients' preferences for the management of anemia. BMC Nephrol (2017) 0.75
Art and Science of Instrument Development for Stated-Preference Methods. Patient (2017) 0.75
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (2011) 5.12
A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med (2014) 5.01
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health (2007) 3.05
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA (2003) 2.50
Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008. Patient (2010) 2.30
A systematic review of stated preference studies reporting public preferences for healthcare priority setting. Patient (2014) 2.15
Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med (2004) 1.66
Discrete choice experiments to measure consumer preferences for health and healthcare. Expert Rev Pharmacoecon Outcomes Res (2002) 1.46
Economic outcome of cardiac CT-based evaluation and standard of care for suspected acute coronary syndrome in the emergency department: a decision analytic model. Acad Radiol (2011) 1.45
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II. Value Health (2009) 1.43
Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE. Health Econ Policy Law (2011) 1.42
Choice experiments in health: the good, the bad, the ugly and toward a brighter future. Health Econ Policy Law (2009) 1.29
Overcoming bias in estimating the volume-outcome relationship. Health Serv Res (2006) 1.26
Modeling the allocation system: principles for robust design before restructuring. Transplantation (2015) 1.26
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes (2003) 1.17
Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery (2011) 1.17
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genet Med (2013) 1.16
Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res (2012) 1.14
A review of studies examining stated preferences for cancer screening. Prev Chronic Dis (2006) 1.14
The social value of a QALY: raising the bar or barring the raise? BMC Health Serv Res (2011) 1.13
Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ (2007) 1.12
Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis. Health Aff (Millwood) (2007) 1.12
Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol (2011) 1.12
Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals. CMAJ (2011) 1.10
A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation. Patient (2012) 1.07
Individual chitin synthase enzymes synthesize microfibrils of differing structure at specific locations in the Candida albicans cell wall. Mol Microbiol (2007) 1.07
Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis (2014) 1.05
CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools. Blood (2009) 1.01
A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. J Rheumatol (2007) 0.99
Identifying possible indicators of systematic overuse of health care procedures with claims data. Med Care (2014) 0.95
Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis. Patient (2015) 0.94
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94
Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis. J Drugs Dermatol (2004) 0.94
Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry. BMC Musculoskelet Disord (2012) 0.94
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists. Drugs (2005) 0.93
Building new roles and relationships in research: a model of patient engagement research. Qual Life Res (2014) 0.93
Patient preferences for the treatment of type 2 diabetes: a scoping review. Pharmacoeconomics (2013) 0.92
Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators. Arthritis Care Res (Hoboken) (2015) 0.92
Survival after transfusion as assessed in a large multistate US cohort. Transfusion (2004) 0.90
Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol (2012) 0.89
Can public reporting impact patient outcomes and disparities? A systematic review. Patient Educ Couns (2013) 0.89
Using comparative effectiveness research to inform decision-making: is there a role of economic evaluation? J Comp Eff Res (2012) 0.89
Societal values in the allocation of healthcare resources: is it all about the health gain? Patient (2011) 0.89
Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies. Int J Technol Assess Health Care (2012) 0.89
The individual and health sector costs of asthma: the first year of a longitudinal study in New South Wales. Aust N Z J Public Health (2005) 0.89
HIV testing preferences in Tanzania: a qualitative exploration of the importance of confidentiality, accessibility, and quality of service. BMC Public Health (2014) 0.89
Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults. BMC Musculoskelet Disord (2012) 0.88
Clopidogrel and percutaneous coronary interventions. JAMA (2003) 0.88
How important is health status in defining quality of life for older people? An exploratory study of the views of older South Australians. Appl Health Econ Health Policy (2014) 0.88
Health technology assessment, research, and implementation within a health region in Alberta, Canada. Int J Technol Assess Health Care (2003) 0.87
Essay for the CIHR/CMAJ award: improving access to hip and knee replacement and its quality by adopting a new model of care in Alberta. CMAJ (2011) 0.87
Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment. Pharmacoeconomics (2014) 0.87
Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment. Int J Technol Assess Health Care (2009) 0.86
Systematic review of comparative effectiveness data for oncology orphan drugs. Am J Manag Care (2012) 0.86
Eliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete-choice experiments. Eur J Hum Genet (2013) 0.86
Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model. J Bone Joint Surg Am (2013) 0.85
Decision making in pediatric oncology: evaluation and incorporation of patient and parent preferences. Pediatr Blood Cancer (2012) 0.84
Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer. Support Care Cancer (2011) 0.84
Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis. Med Decis Making (2011) 0.84
Back pain in seniors: the Back pain Outcomes using Longitudinal Data (BOLD) cohort baseline data. BMC Musculoskelet Disord (2014) 0.83
Comparison of individual and group valuation of health state scenarios across communities in West Africa. Appl Health Econ Health Policy (2006) 0.83
Assessing the impact of palliative care in the intensive care unit through the lens of patient-centered outcomes research. Curr Opin Crit Care (2013) 0.83
What outcomes should US policy makers compare in comparative effectiveness research? Expert Rev Pharmacoecon Outcomes Res (2010) 0.83
Compulsive cell phone use and history of motor vehicle crash. J Adolesc Health (2013) 0.82
Functional status decline as a measure of adverse events in home health care: an observational study. BMC Health Serv Res (2006) 0.82
Patients' preferences for healthcare system reforms in Hungary: a conjoint analysis. Appl Health Econ Health Policy (2006) 0.82
Reducing disparities in breast cancer survival--the effect of large-scale screening of the uninsured. Breast J (2011) 0.82
Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia. J Clin Epidemiol (2012) 0.82
Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev (2009) 0.81
Patient and parent preferences for immunoglobulin treatments: a conjoint analysis. J Med Econ (2012) 0.81
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. J Thorac Oncol (2014) 0.81
Can patients diagnosed with schizophrenia complete choice-based conjoint analysis tasks? Patient (2011) 0.81
Assessment of parents' preferences for the treatment of school-age children with ADHD: a discrete choice experiment. Expert Rev Pharmacoecon Outcomes Res (2011) 0.81
A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children. Psychiatr Serv (2014) 0.80
Does bearing size influence metal ion levels in large-head metal-on-metal total hip arthroplasty? A comparison of three total hip systems. J Orthop Surg Res (2014) 0.80
Attitudes toward infection prophylaxis in pediatric oncology: a qualitative approach. PLoS One (2012) 0.80
Guidelines for health technologies: specific guidance for oncology products in Canada. Value Health (2012) 0.80
The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US. Curr Med Res Opin (2004) 0.80
A Markov decision process approach to multi-category patient scheduling in a diagnostic facility. Artif Intell Med (2011) 0.80
Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment. Arthritis Care Res (Hoboken) (2012) 0.79
Cost-effectiveness analysis of the New South Wales adult drug court program. Eval Rev (2004) 0.79
An environmental scan of advance care planning decision AIDS for patients undergoing major surgery: a study protocol. Patient (2014) 0.79
Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination. J Infect Dis (2011) 0.79
Sources of variation in the costs of health care for asthma patients in Australia. J Health Serv Res Policy (2009) 0.79
Assessing comparative effectiveness research in the US. Appl Health Econ Health Policy (2009) 0.78
Group decision making with the analytic hierarchy process in benefit-risk assessment: a tutorial. Patient (2014) 0.78
[Patient survey in general practice: development, validation and application of a survey instrument]. Z Arztl Fortbild Qualitatssich (2004) 0.78
Diagnosis and prognosis of Australia's health information for evidence-based policy. J Health Serv Res Policy (2002) 0.78
Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000. Can J Cardiol (2003) 0.77
Understanding consumer preferences in the context of managed competition: evidence from a choice experiment in Colombia. Appl Health Econ Health Policy (2012) 0.77
A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma. Pharmacoeconomics (2012) 0.77
Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment. Psychiatr Serv (2014) 0.77
The role of the patient in promoting patient-centered outcomes research. Patient (2008) 0.77
Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh. Int J Technol Assess Health Care (2008) 0.77
One size does not fit all: HIV testing preferences differ among high-risk groups in Northern Tanzania. AIDS Care (2015) 0.77
Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits. Acad Radiol (2012) 0.77
An index for measuring overuse of health care resources with Medicare claims. Med Care (2015) 0.76
Determinants of influenza vaccine purchasing decision in the US: a conjoint analysis. Vaccine (2010) 0.76